NDC 59762-1389-7 - Doxazosin mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1389
- Requested NDC
- 59762-1389-7
- Package NDCs from labels
- 59762-1389-7
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin mesylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-1389-7 | Doxazosin mesylate | 100 in 1 BOTTLE | TABLET | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-1389 | DOXAZOSIN MESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 1 | Current NDC, 1 package rows | 20250511_2e524986-7903-416f-b2b8-d27295103e75.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Major Pharmaceuticals | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 2026-08-05 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | 71815e8f-33ed-4f36-a8ec-d4443151a9d8 | 2026-07-08 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Golden State Medical Supply, Inc. | 54eeef3d-c906-37e7-e063-6294a90afca2 | 2026-06-23 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | ec06f008-37a1-4757-a3ee-0b4720912bc4 | 2026-06-11 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | PD-Rx Pharmaceuticals, Inc. | 2ea9bb6b-a4f0-496a-b27b-4454167a4b70 | 2026-05-13 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Cardinal Health 107, LLC | 08521333-ff21-45ad-b99e-1f43d945d24d | 2026-04-24 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 277c3278-4fe2-47ac-9115-15b417325ffd | 2026-04-13 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | 2110eec5-949d-4718-ad6d-3629e5db8a07 | 2026-04-08 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | e046e0b7-f510-4318-9884-034d683864d4 | 2026-04-08 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | AvPAK | de9ab9a4-d8b8-8b36-e053-2a95a90aaa35 | 2026-03-24 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | AvKARE | e3d381c1-3b2f-af70-f4e6-08d6202eed25 | 2026-03-24 | Warnings, Adverse reactions | 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | e2f5d7d2-21aa-4921-8035-da945d3c565c | 2026-03-04 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 54116886-ea5e-5320-e054-00144ff8d46c | 2026-02-16 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 2026-02-13 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 54549d19-6311-4dbb-8622-fd3e5440551a | 2026-01-29 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f2b35586-d550-3fcb-e053-2995a90a3403 | 2026-01-19 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Northwind Health Company, LLC | f6c9856e-9154-f349-e053-6294a90a9f2c | 2026-01-19 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f306adae-a2fe-5477-e053-2995a90a7838 | 2026-01-01 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| B03 Sinus Relief | ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS | Apex Energetics Inc. | bad83f77-e9ae-7118-e053-2a95a90aa737 | 2025-12-31 | Warnings | J2B2A4N98G |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 7aeaa0e1-136c-444d-b66c-7a5a96fb3022 | 2025-12-05 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.